Literature DB >> 26957094

Translating Inhibitory Fc Receptor Biology into Novel Therapeutic Approaches.

Falk Nimmerjahn1.   

Abstract

Innate and adaptive immune responses represent well balanced reactions aimed at resolving microbial infections without causing major collateral damage to the host. Disturbances in this system either due to enhanced activating or decreased inhibitory signaling pathways may lead to excessive immune activation resulting in tissue damage, the induction of autoimmune disease and/or chronic inflammation. On the molecular level this balance is achieved by the integration of inhibitory and activating signals, which are delivered by pairs of activating and inhibitory cell surface receptors expressed on innate and adaptive immune cells. The regulation of immunoglobulin G activity through cellular Fc receptors is a prime example for this type of regulation. This is not only relevant for the regulation of antibody-mediated effector functions through innate immune effector cells but also for the regulation of B cell activation and antibody production itself.

Entities:  

Keywords:  Fc receptor; antibody; autoimmunity; immunoglobulin G; inflammation

Mesh:

Substances:

Year:  2016        PMID: 26957094     DOI: 10.1007/s10875-016-0249-6

Source DB:  PubMed          Journal:  J Clin Immunol        ISSN: 0271-9142            Impact factor:   8.317


  45 in total

1.  Divergent immunoglobulin g subclass activity through selective Fc receptor binding.

Authors:  Falk Nimmerjahn; Jeffrey V Ravetch
Journal:  Science       Date:  2005-12-02       Impact factor: 47.728

2.  Anti-inflammatory activity of immunoglobulin G resulting from Fc sialylation.

Authors:  Yoshikatsu Kaneko; Falk Nimmerjahn; Jeffrey V Ravetch
Journal:  Science       Date:  2006-08-04       Impact factor: 47.728

3.  Antitumor activities of agonistic anti-TNFR antibodies require differential FcγRIIB coengagement in vivo.

Authors:  Fubin Li; Jeffrey V Ravetch
Journal:  Proc Natl Acad Sci U S A       Date:  2013-11-11       Impact factor: 11.205

Review 4.  Intravenous immunoglobulin therapy: how does IgG modulate the immune system?

Authors:  Inessa Schwab; Falk Nimmerjahn
Journal:  Nat Rev Immunol       Date:  2013-02-15       Impact factor: 53.106

5.  Broad requirement for terminal sialic acid residues and FcγRIIB for the preventive and therapeutic activity of intravenous immunoglobulins in vivo.

Authors:  Inessa Schwab; Sidonia Mihai; Michaela Seeling; Michael Kasperkiewicz; Ralf J Ludwig; Falk Nimmerjahn
Journal:  Eur J Immunol       Date:  2014-03-07       Impact factor: 5.532

6.  Spontaneous autoimmune disease in Fc(gamma)RIIB-deficient mice results from strain-specific epistasis.

Authors:  S Bolland; J V Ravetch
Journal:  Immunity       Date:  2000-08       Impact factor: 31.745

7.  Fc receptors are required in passive and active immunity to melanoma.

Authors:  R Clynes; Y Takechi; Y Moroi; A Houghton; J V Ravetch
Journal:  Proc Natl Acad Sci U S A       Date:  1998-01-20       Impact factor: 11.205

8.  Impaired inhibitory Fcgamma receptor IIB expression on B cells in chronic inflammatory demyelinating polyneuropathy.

Authors:  Björn Tackenberg; Ilijas Jelcic; Anne Baerenwaldt; Wolfgang H Oertel; Norbert Sommer; Falk Nimmerjahn; Jan D Lünemann
Journal:  Proc Natl Acad Sci U S A       Date:  2009-03-04       Impact factor: 11.205

9.  Augmented humoral and anaphylactic responses in Fc gamma RII-deficient mice.

Authors:  T Takai; M Ono; M Hikida; H Ohmori; J V Ravetch
Journal:  Nature       Date:  1996-01-25       Impact factor: 49.962

10.  The innate mononuclear phagocyte network depletes B lymphocytes through Fc receptor-dependent mechanisms during anti-CD20 antibody immunotherapy.

Authors:  Junji Uchida; Yasuhito Hamaguchi; Julie A Oliver; Jeffrey V Ravetch; Jonathan C Poe; Karen M Haas; Thomas F Tedder
Journal:  J Exp Med       Date:  2004-06-21       Impact factor: 14.307

View more
  7 in total

1.  Ins and Outs of Antibodies.

Authors:  Sudhir Gupta
Journal:  J Clin Immunol       Date:  2016-05-12       Impact factor: 8.317

Review 2.  Antibody-mediated protection against Ebola virus.

Authors:  Erica Ollmann Saphire; Sharon L Schendel; Bronwyn M Gunn; Jacob C Milligan; Galit Alter
Journal:  Nat Immunol       Date:  2018-10-17       Impact factor: 25.606

Review 3.  Fc gamma receptors: glycobiology and therapeutic prospects.

Authors:  Jerrard M Hayes; Mark R Wormald; Pauline M Rudd; Gavin P Davey
Journal:  J Inflamm Res       Date:  2016-11-16

4.  Modulation of Microglial Cell Fcγ Receptor Expression Following Viral Brain Infection.

Authors:  Priyanka Chauhan; Shuxian Hu; Wen S Sheng; Sujata Prasad; James R Lokensgard
Journal:  Sci Rep       Date:  2017-02-06       Impact factor: 4.379

5.  Targeting of embryonic annexin A2 expressed on ovarian and breast cancer by the novel monoclonal antibody 2448.

Authors:  Simeon Cua; Heng Liang Tan; Wey Jia Fong; Angela Chin; Ally Lau; Vanessa Ding; Zhiwei Song; Yuansheng Yang; Andre Choo
Journal:  Oncotarget       Date:  2018-01-10

6.  Impact of Human FcγR Gene Polymorphisms on IgG-Triggered Cytokine Release: Critical Importance of Cell Assay Format.

Authors:  Khiyam Hussain; Chantal E Hargreaves; Tania F Rowley; Joshua M Sopp; Kate V Latham; Pallavi Bhatta; John Sherington; Rona M Cutler; David P Humphreys; Martin J Glennie; Jonathan C Strefford; Mark S Cragg
Journal:  Front Immunol       Date:  2019-03-07       Impact factor: 7.561

Review 7.  Dendritic Cell Tumor Vaccination via Fc Gamma Receptor Targeting: Lessons Learned from Pre-Clinical and Translational Studies.

Authors:  Enrique Gómez Alcaide; Sinduya Krishnarajah; Fabian Junker
Journal:  Vaccines (Basel)       Date:  2021-04-20
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.